NeuroMetrix Inc (NURO)

1.56
NASDAQ : Health Care
Prev Close 1.56
Day Low/High 0.00 / 0.00
52 Wk Low/High 1.35 / 3.72
Avg Volume 89.20K
Exchange NASDAQ
Shares Outstanding 5.12M
Market Cap 8.19M
EPS -7.80
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

NeuroMetrix Wins Electronics Retailer Association Award For Quell TV Advertising

NeuroMetrix Wins Electronics Retailer Association Award For Quell TV Advertising

NeuroMetrix, Inc. (NASDAQ:NURO) today announced that the Company's Quell ® Wearable Pain Relief Technology™ has won the Electronics Retailer Association Moxie Award for the Best Health Show 2016.

NeuroMetrix Reports Final Approval To Market DPNCheck In China

NeuroMetrix Reports Final Approval To Market DPNCheck In China

NeuroMetrix, Inc. (Nasdaq: NURO) today reported final regulatory approval in China for DPNCheck ®, a diagnostic test for peripheral neuropathy.

NeuroMetrix Announces Quell Dispensing Partnership With Comprehensive Pain Specialists

NeuroMetrix Announces Quell Dispensing Partnership With Comprehensive Pain Specialists

NeuroMetrix, Inc. (Nasdaq: NURO) announced today that Comprehensive Pain Specialists will offer Quell ® Wearable Pain Relief Technology™ in selected clinic locations.

NeuroMetrix Announces Participation At The 18th Annual Rodman & Renshaw Global Investment Conference In New York City September 11-13th, 2016

NeuroMetrix Announces Participation At The 18th Annual Rodman & Renshaw Global Investment Conference In New York City September 11-13th, 2016

NeuroMetrix, Inc. (NASDAQ:NURO) today announced it will be featured as a presenting company at the 18 th Annual Rodman & Renshaw Global Investment Conference, sponsored by H.

NeuroMetrix Announces Issuance Of Patent For DPNCheck Core Technology In China

NeuroMetrix Announces Issuance Of Patent For DPNCheck Core Technology In China

NeuroMetrix, Inc. (Nasdaq: NURO) announced today that the State Intellectual Property Office of the People's Republic of China has issued Chinese Patent No.

NeuroMetrix Launches New Website To Support Growth Of Quell Wearable Pain Relief Technology

NeuroMetrix Launches New Website To Support Growth Of Quell Wearable Pain Relief Technology

NeuroMetrix, Inc. (NASDAQ:NURO) today announced the launch of a new website to promote Quell ®, the company's rapidly growing pain relief brand.

NeuroMetrix Announces That Quell Will Be Featured In The Target Open House

NeuroMetrix Announces That Quell Will Be Featured In The Target Open House

NeuroMetrix, Inc. (Nasdaq: NURO) announced today that Quell ® will be featured in the Target Open House in San Francisco.

NeuroMetrix Celebrates 10,000 Quell Facebook Fans With Pain Awareness Month Contest

NeuroMetrix Celebrates 10,000 Quell Facebook Fans With Pain Awareness Month Contest

NeuroMetrix, Inc. (NASDAQ:NURO) announced today that to celebrate having reached 10,000 fans for Quell ® Pain Relief on Facebook, it will give away a contest prize each day during September which is Pain Awareness...

NeuroMetrix Commentary On Strategic And Business Partnerships For Quell Wearable Pain Relief Technology

NeuroMetrix Commentary On Strategic And Business Partnerships For Quell Wearable Pain Relief Technology

NeuroMetrix, Inc. (NASDAQ:NURO) today provided commentary on its Quell ® partnership strategy.

NeuroMetrix To Present Quell Wearable Pain Technology At National Association Of Chain Drug Stores Total Store Expo

NeuroMetrix To Present Quell Wearable Pain Technology At National Association Of Chain Drug Stores Total Store Expo

NeuroMetrix, Inc. (NASDAQ:NURO) today announced that the company, in partnership with Advantage Healthcare, will explore Quell ® retail expansion plans with executives from key national and regional drug...

NeuroMetrix Reports That The Quell Health Cloud Has Collected Over 1 Million Hours Of Quell Therapy And Health Data

NeuroMetrix Reports That The Quell Health Cloud Has Collected Over 1 Million Hours Of Quell Therapy And Health Data

NeuroMetrix, Inc. (NASDAQ:NURO) announced a major milestone with over 1 million hours of Quell ® therapy and health data uploaded to the Quell Health Cloud as of August 1, 2016.

NeuroMetrix Reports Recent Media Coverage For Quell

NeuroMetrix Reports Recent Media Coverage For Quell

NeuroMetrix, Inc. (NASDAQ:NURO) today reported continued strong media attention focusing on the company's innovative Quell ® Wearable Pain Relief Technology ™.

NeuroMetrix Reports Q2 2016 Financial Results And Highlights

NeuroMetrix Reports Q2 2016 Financial Results And Highlights

NeuroMetrix, Inc. (Nasdaq: NURO), today reported financial and business highlights for the quarter and six month periods ended June 30, 2016.

NeuroMetrix, Inc. Announces Date For 2016 Second Quarter Financial Results Conference Call

NeuroMetrix, Inc. Announces Date For 2016 Second Quarter Financial Results Conference Call

NeuroMetrix, Inc. (NASDAQ:NURO) announced today that it plans to issue its 2016 second quarter financial results before the opening of the market on Thursday July 21, 2016.

NeuroMetrix Expands DPNCheck Commercialization In Mexico

NeuroMetrix Expands DPNCheck Commercialization In Mexico

NeuroMetrix, Inc. ( NURO) today reported commercial expansion of DPNCheck ® in Mexico following receipt of a purchase order from one of Mexico's six major government healthcare institutions.

NeuroMetrix' Quell Device Makes Second Appearance At The American Podiatric Medical Association Annual Scientific Meeting

NeuroMetrix' Quell Device Makes Second Appearance At The American Podiatric Medical Association Annual Scientific Meeting

NeuroMetrix, Inc. (NASDAQ:NURO) today announced that Quell ® Wearable Pain Relief Technology ™ will be featured for the second year in a row at the American Podiatric Medical Association's Annual Scientific...

NeuroMetrix Announces Launch Of Quell Sport Electrode

NeuroMetrix Announces Launch Of Quell Sport Electrode

NeuroMetrix, Inc. (Nasdaq: NURO) today announced commercial launch of a new Sport Electrode for its innovative Quell ® Wearable Pain Relief Technology™.

NeuroMetrix Reports Peer-Reviewed Publication Of Initial Quell Study

NeuroMetrix Reports Peer-Reviewed Publication Of Initial Quell Study

NeuroMetrix, Inc. (Nasdaq: NURO), today reported publication of the initial Quell ® study in the Journal of Pain Research.

NeuroMetrix Announces Quell Distribution Agreement With WBC Group

NeuroMetrix Announces Quell Distribution Agreement With WBC Group

NeuroMetrix, Inc. (Nasdaq: NURO) announced today that WBC Group, LLC will be the exclusive distributor of Quell ® Wearable Pain Relief Technology ™ to chiropractors, physical therapists, physical fitness...

NeuroMetrix To Sponsor Clinical Study At The Scripps Translational Science Institute Assessing The Impact Of Quell Technology On Opioid Use And Pain In Cancer Patients

NeuroMetrix To Sponsor Clinical Study At The Scripps Translational Science Institute Assessing The Impact Of Quell Technology On Opioid Use And Pain In Cancer Patients

NeuroMetrix, Inc. (Nasdaq: NURO) and the Scripps Translational Science Institute (STSI) today announced a clinical study of Quell ® wearable pain relief technology in patients with cancer related pain.

NeuroMetrix Submits CE Mark Application For Quell Wearable Pain Relief Device

NeuroMetrix Submits CE Mark Application For Quell Wearable Pain Relief Device

NeuroMetrix, Inc. (Nasdaq: NURO) announced today that a CE (Conformité Européenne ) Technical File Application for Quell ® has been submitted to TUV SUD Product Service GmbH, which is one of the...

NeuroMetrix Showcases Quell Technology At The Western Foot & Ankle Conference

NeuroMetrix Showcases Quell Technology At The Western Foot & Ankle Conference

NeuroMetrix, Inc. (NASDAQ:NURO) today announced that Quell ® Wearable Pain Relief Technology™ will be featured at the Western Foot & Ankle Conference to be held June 23-26 in Anaheim, CA.

NeuroMetrix Announces Quell Distribution In Canada

NeuroMetrix Announces Quell Distribution In Canada

 NeuroMetrix, Inc. (Nasdaq: NURO) announced today that Quell ® Wearable Pain Relief Technology ™ is available in Canada via Amazon Canada.

NeuroMetrix Reports Executive Stock Transactions During May 2016

NeuroMetrix Reports Executive Stock Transactions During May 2016

NeuroMetrix, Inc. (Nasdaq: NURO) which developed and markets Quell ® Wearable Pain Relief Technology ™, reported purchases during May 2016 of the company's common stock by its Chief Executive Officer, Dr.

NeuroMetrix Showcases Quell Technology At SLEEP 2016, The 30th Anniversary Meeting Of The Associated Professional Sleep Societies

NeuroMetrix Showcases Quell Technology At SLEEP 2016, The 30th Anniversary Meeting Of The Associated Professional Sleep Societies

NeuroMetrix, Inc. (NASDAQ:NURO) today announced that Quell ® Wearable Pain Relief Technology ™ will be featured at SLEEP 2016, which is a joint meeting of the American Academy of Sleep Medicine and the...

NeuroMetrix Closes $21.3 Million At-The-Market Private Placement Of Preferred Stock And Warrants And Redeems $13.8 Million Of Outstanding Preferred Stock

NeuroMetrix Closes $21.3 Million At-The-Market Private Placement Of Preferred Stock And Warrants And Redeems $13.8 Million Of Outstanding Preferred Stock

NeuroMetrix, Inc. (Nasdaq: NURO) reported that it has closed its previously announced private placement of preferred stock and warrants.

NeuroMetrix Celebrates 20 Year Anniversary

NeuroMetrix Celebrates 20 Year Anniversary

NeuroMetrix, Inc. (Nasdaq: NURO) announced today that it is celebrating its twenty year anniversary.

NeuroMetrix Announces $21.3 Million At The Market Private Placement Of Preferred Stock And Warrants

NeuroMetrix Announces $21.3 Million At The Market Private Placement Of Preferred Stock And Warrants

NeuroMetrix, Inc. (NASDAQ: NURO) announced today that it entered into a definitive securities purchase agreement with a healthcare dedicated institutional investor in connection with a private placement of 21,300 shares of...